drugset / Trial / NCT01798186
Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation
Phase 1
Completed
26 enrolled
Johns Hopkins University
RTI International · collabSubstance Abuse and Mental Health Services Administration (SAMHSA) · collab
RandomizedParallel-groupSingle-blindDiagnostic
Summary
This primary aim of this study is to assess the effects of passive (second-hand) inhalation of cannabis smoke on toxicological analysis of "native" oral fluid (saliva), urine and blood specimens. The results of this study will help inform the validity of oral fluid as a biomarker of cannabis exposure and to determine whether, and for how long, passive inhalation of cannabis smoke could result in a positive toxicology result.
Timeline
- Start
- 2013-05
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabis | Traditional medicine (herbal / TCM) | — | — |
Indications
No indication recorded.